. The Company is in advanced discussions with other potential partners and we look forward to further strong results in the second half of FY2019.”
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025